Tobacco cessation in patients with pulmonary carcinoma

Tobacco cessation in patients with pulmonary carcinoma - TEMPO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026813

Enrollment

188

Registered

2021-12-23

Start date

2021-12-03

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34.9 F17.2 F17

Interventions

Group 1: Part A, cross-sectional survey (case-control study): Active smoking and non-smoking patients with pulmonary carcinoma will be assessed with questionnaires on sociodemographics, "Fagerström",

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patient of the Cancer Center - Diagnosis of a tumor disease of the lung - Ability to give consent - Subject must be able to understand the subject information and to give informed consent in writing and on an individual basis.

Exclusion criteria

Exclusion criteria: - Patients who are unable to form a natural will and are therefore incapable of giving consent. - Patients with acute suicidal tendencies

Design outcomes

Primary

Measure	Time frame
patient-relevant "soft" endpoint: Quality of life (McGill Quality of Life)	—

Secondary

Measure	Time frame
"Hard" endpoint: abstinence (measured via self-report, CO measurements of breath, and urine tests of cotinine levels at group completion)	—

Countries

Germany

Contacts

Public ContactMarcus Gertzen

Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Universität Augsburg, BKH Augsburg

Marcus.Gertzen@bkh-augsburg.de+49 (0) 821 4803 - 3710

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026